The latest news from academia, regulators
research labs and other things of interest
Posted: May 23, 2013
Senior Scientific Receives U.S. Patent for the Detection, Measurement and Imaging of Cancer Cells Using Nanoparticles
(Nanowerk News) Senior Scientific, LLC, a unit of Manhattan Scientifics and a developer of molecular imaging and nanobiotechnology for the early detection and localization of cancer and other human diseases, today announced that the United States Patent Office (USPTO) has issued U.S. Patent No. 8,447,379 entitled “Detection, measurement, and imaging of cells such as cancer and other biologic substances using targeted nanoparticles and magnetic properties thereof.”
The patent includes claims directed to detecting and measuring biological substances such as cancer cells. The methods can be used in humans, with no harmful radiation, and can find cancers much earlier than is possible with conventional technologies.
The technology is based on the work of Edward R. Flynn, PhD, in NanoMagnetic Relaxometry™. The issued patent is further confirmation of the pioneering nature of Dr. Flynn’s work.
Gerald Grafe, president of Senior Scientific, said, “We are moving forward and making progress to bring Dr. Flynn’s technology to market, and this patent is an important addition to our intellectual property estate protecting the commercial value of the work.”
Dr. Flynn, Chief Scientist of Senior Scientific, said, “I am encouraged to see my work heading to market, and pleased that we now also have this patent to protect the business.”
About Manhattan Scientifics
Manhattan Scientifics Inc. (http://www.mhtx.com), located in New Mexico, New York and Montreal, is focused on technology transfer and commercialization of disruptive technologies in the nano-medicine space. It has achieved several critical milestones in the development of its proprietary technology for the early detection and treatment of cancer. The company also is diligently working with its commercial partners to build super-strength metals and alloys to make extremely light weight products. The company is developing commercial medical prosthetics applications for its ultra-fine grain metals and plans to commercialize the cancer research work and nano-medical applications developed by Senior Scientific LLC, a unit of the company.
About Senior Scientific
Senior Scientific, LLC (http://www.seniorscientific.com) is a New Mexico Company with research facilities located at the University of New Mexico Science and Technology Park in Albuquerque, New Mexico and longstanding relationships with the University of New Mexico Health Sciences Center, and the Center for Integrated Nanotechnology (CINT) at Sandia National Laboratory. The Company’s focus is in the emerging field of molecular imaging and nanobiotechnology for the early detection and localization of cancer and other human diseases, and is the leader in a technology called Nanomagnetic Relaxometry (“NMR”). Its proprietary technologies and methods employ magnetic nanoparticles targeted towards cells associated with cancer and other diseases, and detect those cells tagged with magnetic nanoparticles through sophisticated magnetic sensors.
Source: Manhattan Scientifics (press release)
If you liked this article, please give it a quick review on reddit or StumbleUpon. Thanks!
Check out these other trending stories on Nanowerk: